Effect of Thiazolidinediones on Albuminuria and Proteinuria in Diabetes: A Meta-analysis

Treatment with thiazolidinediones significantly decreases urinary albumin and protein excretion in patients with diabetes. This finding calls for clinical trials with hard renal outcomes to elucidate the potential benefits of thiazolidinediones on diabetic nephropathy.